Company: ABUS
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001447028-25-000126
Chunk: 16

Company: Arbutus Biopharma Corp
Filing Date: 2025-11-13
Form: 10-Q
Item: Part II, Item 3
Chunk 16
---
) Condensed Consolidated Balance Sheets; (ii) Condensed Consolidated Statements of Operations; (iii) Condensed Consolidated Statements of Comprehensive Income (Loss); (iv) Condensed Consolidated Statements of Stockholders’ Equity; (v) Condensed Consolidated Statements of Cash Flows; and (vi) Notes to Condensed Consolidated Financial Statements.    104Cover page interactive data file (embedded within the inline XBRL document and included in Exhibit 101).

*    Filed herewith.

**    Furnished herewith.

40

SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on November 13, 2025.

ARBUTUS BIOPHARMA CORPORATION By:/s/ Lindsay Androski  Lindsay Androski  President and Chief Executive Officer(Principal Executive Officer)By:/s/ Tuan NguyenTuan NguyenChief Financial Officer(Principal Financial Officer and Principal Accounting Officer)

41